With EMPA treatment, although we observed a minimal effect in BP, there was also a decrease of renal ACE mRNA, protein, and enzymatic activity along with decreased AT1R mRNA in treated PCOS rats. This evidence concerns the gene ACE and polycystic ovary syndrome.